• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类免疫缺陷病毒感染合并中枢神经系统受累时抗逆转录病毒疗法的调整

Adaptation of antiretroviral therapy in human immunodeficiency virus infection with central nervous system involvement.

作者信息

Mehling Matthias, Drechsler Henning, Kuhle Jens, Hardmeier Martin, Doerries Ruediger, Ruegg Stephan, Gass Achim

机构信息

Department of Neurology, University Hospital of Basel, Switzerland.

出版信息

J Neurovirol. 2008 Jan;14(1):78-84. doi: 10.1080/13550280701793940.

DOI:10.1080/13550280701793940
PMID:18300078
Abstract

The authors describe a patient with known human immunodeficiency virus (HIV)-1 infection who presented with two generalized seizures and was found to have extensive white matter disease and a left/bilateral temporo-occipital focal slowing on electroencephalography (EEG). There were no magnetic resonance imaging (MRI) or cerebrospinal fluid (CSF) indications for opportunistic infection. Plasma viremia was controlled, whereas viral replication was uncontrolled in CSF. CSF-specific genotype-guided adaptation of the antiretroviral therapy in order to optimize central nervous system (CNS) penetration resulted in clinical improvement and normalization of MRI and EEG. Our case report illustrates the importance of individualized antiretroviral therapy in HIV infected patients with neurological complications.

摘要

作者描述了一名已知感染人类免疫缺陷病毒1型(HIV-1)的患者,该患者出现两次全身性癫痫发作,脑电图(EEG)显示有广泛的白质病变以及左/双侧颞枕叶局灶性慢波。磁共振成像(MRI)或脑脊液(CSF)检查均未显示机会性感染迹象。血浆病毒血症得到控制,而脑脊液中的病毒复制未得到控制。根据脑脊液特异性基因型指导调整抗逆转录病毒疗法,以优化中枢神经系统(CNS)的药物渗透,从而使临床症状改善,MRI和EEG恢复正常。我们的病例报告说明了个体化抗逆转录病毒疗法在伴有神经系统并发症的HIV感染患者中的重要性。

相似文献

1
Adaptation of antiretroviral therapy in human immunodeficiency virus infection with central nervous system involvement.人类免疫缺陷病毒感染合并中枢神经系统受累时抗逆转录病毒疗法的调整
J Neurovirol. 2008 Jan;14(1):78-84. doi: 10.1080/13550280701793940.
2
[Human immunodeficiency virus and Chagas disease coinfection treated successfully with benznidazole and a raltegravir-based antiretroviral regimen: a case report].
Med Clin (Barc). 2011 Sep 10;137(6):278-9. doi: 10.1016/j.medcli.2010.06.013. Epub 2010 Oct 25.
3
Pharmacokinetics of two common antiretroviral regimens in older HIV-infected patients: a pilot study.两种常见抗逆转录病毒方案在老年 HIV 感染患者中的药代动力学:一项初步研究。
HIV Med. 2013 Aug;14(7):401-9. doi: 10.1111/hiv.12017. Epub 2013 Feb 24.
4
Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens.血清脂质水平与HIV血清学状态、特定抗逆转录病毒药物及治疗方案的关联。
J Acquir Immune Defic Syndr. 2007 May 1;45(1):34-42. doi: 10.1097/QAI.0b013e318042d5fe.
5
[Atazanavir-induced nephrolithiasis].
Enferm Infecc Microbiol Clin. 2009 Feb;27(2):134-5. doi: 10.1016/j.eimc.2007.12.001. Epub 2009 Feb 25.
6
Effects of the H2-receptor antagonist famotidine on the pharmacokinetics of atazanavir-ritonavir with or without tenofovir in HIV-infected patients.在 HIV 感染患者中,H2 受体拮抗剂法莫替丁对含或不含替诺福韦的阿扎那韦-利托那韦的药代动力学的影响。
AIDS Patient Care STDS. 2011 Sep;25(9):509-15. doi: 10.1089/apc.2011.0113. Epub 2011 Jul 19.
7
Assessment of pharmacokinetic interactions of the HCV NS5A replication complex inhibitor daclatasvir with antiretroviral agents: ritonavir-boosted atazanavir, efavirenz and tenofovir.丙型肝炎病毒NS5A复制复合体抑制剂达卡他韦与抗逆转录病毒药物的药代动力学相互作用评估:利托那韦增强的阿扎那韦、依非韦伦和替诺福韦
Antivir Ther. 2013;18(7):931-40. doi: 10.3851/IMP2674. Epub 2013 Aug 20.
8
Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis.女性生殖道中的抗逆转录病毒药物暴露:对口服暴露前和暴露后预防的影响。
AIDS. 2007 Sep 12;21(14):1899-907. doi: 10.1097/QAD.0b013e328270385a.
9
Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naïve adults: 48-week results from the Antiretroviral Regimen Evaluation Study (ARES).在初治成人抗逆转录病毒治疗中,两种每日一次方案与由奈非那韦、去羟肌苷和司他夫定组成的方案的比较:抗逆转录病毒治疗方案评估研究(ARES)的48周结果。
HIV Clin Trials. 2005 Sep-Oct;6(5):235-45. doi: 10.1310/A686-M37Y-J2PT-E9GJ.
10
Steady-state pharmacokinetics of tenofovir-based regimens in HIV-infected pediatric patients.替诺福韦方案在 HIV 感染儿科患者中的稳态药代动力学。
Antimicrob Agents Chemother. 2011 Sep;55(9):4290-4. doi: 10.1128/AAC.01334-10. Epub 2011 Jun 13.

引用本文的文献

1
Should antiretroviral therapy for HIV infection be tailored for intracerebral penetration?针对HIV感染的抗逆转录病毒疗法是否应根据脑内渗透情况进行调整?
Neth J Med. 2009 Jun;67(6):206-11.
2
Voltage-gated potassium channels in human immunodeficiency virus type-1 (HIV-1)-associated neurocognitive disorders.1型人类免疫缺陷病毒(HIV-1)相关神经认知障碍中的电压门控钾通道
J Neuroimmune Pharmacol. 2009 Mar;4(1):60-70. doi: 10.1007/s11481-008-9106-6. Epub 2008 May 6.

本文引用的文献

1
Frequency of seizures and epilepsy in neurological HIV-infected patients.神经学方面感染艾滋病毒患者的癫痫发作频率和癫痫情况
Seizure. 2008 Jan;17(1):27-33. doi: 10.1016/j.seizure.2007.05.017. Epub 2007 Jul 6.
2
Stability of the latent reservoir for HIV-1 in patients receiving valproic acid.接受丙戊酸治疗的患者中HIV-1潜伏库的稳定性。
J Infect Dis. 2007 Mar 15;195(6):833-6. doi: 10.1086/511823. Epub 2007 Jan 30.
3
Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients.HIV感染患者中枢神经系统中的免疫重建炎症综合征。
Neurology. 2006 Aug 8;67(3):383-8. doi: 10.1212/01.wnl.0000227922.22293.93.
4
HIV pharmacology: barriers to the eradication of HIV from the CNS.HIV药理学:从中枢神经系统根除HIV的障碍
HIV Clin Trials. 2006 May-Jun;7(3):142-53. doi: 10.1310/AW2H-TP5C-NP43-K6BY.
5
Approach to salvage antiretroviral therapy in heavily antiretroviral-experienced HIV-positive adults.在大量接受过抗逆转录病毒治疗的HIV阳性成年患者中实施挽救性抗逆转录病毒治疗的方法。
Lancet Infect Dis. 2006 Aug;6(8):496-507. doi: 10.1016/S1473-3099(06)70550-3.
6
Carbamazepine toxicity induced by lopinavir/ritonavir and nelfinavir.洛匹那韦/利托那韦和奈非那韦引起的卡马西平毒性。
Ann Pharmacother. 2006 Jun;40(6):1190-5. doi: 10.1345/aph.1G630. Epub 2006 May 23.
7
Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report.丙戊酸辅助治疗HIV相关认知障碍:首例报告。
Neurology. 2006 Mar 28;66(6):919-21. doi: 10.1212/01.wnl.0000204294.28189.03. Epub 2006 Mar 1.
8
Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma.脑脊液(CSF)穿透性抗逆转录病毒药物对神经组织中HIV的疗效:脑脊液和血浆中不同的表型耐药模式。
Clin Infect Dis. 2005 Dec 15;41(12):1787-93. doi: 10.1086/498310. Epub 2005 Nov 10.
9
Neurological complications of HIV infection.人类免疫缺陷病毒感染的神经并发症
Lancet Neurol. 2005 Sep;4(9):543-55. doi: 10.1016/S1474-4422(05)70165-4.
10
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study.体内潜伏性HIV-1感染的清除:一项概念验证研究。
Lancet. 2005;366(9485):549-55. doi: 10.1016/S0140-6736(05)67098-5.